Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $5.78-$16.44 |
Market Cap | $2.3B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $55.7M |
Revenue Growth (YoY) | -5.7% |
Gross Profit (12 Mos) | -$137.7M |
Diluted EPS | -$1.43 |
News
See moreYahoo Finance • 13 days ago
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD
Yahoo Finance • last month
Healthcare Names Post Strong After-Hours Moves: KYMR, OCUL, POAI Among Top Gainers
Yahoo Finance • last month
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Ocular Therapeutix prices $475M stock offering
About
CEO | Dr. Pravin U. Dugel M.D. |
CFO | Mr. Donald Notman Jr. |
Address | 15 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 274 |
